Unprescribed Truths: Inside the Weight Loss Drug Craze - The Insight Report

The global obsession with quick-fix weight loss has found its modern holy grail in GLP-1 receptor agonists. Marketed under brand names like Ozempic, Wegovy, Mounjaro, and Zepbound, these injectable medications have transformed from specialized clinical treatments into pop-culture phenomena. In a recent deep-dive episode of The Insight Report, host Gautam Kapil unpacked the multi-billion-dollar machinery driving this trend, revealing the health risks, aggressive marketing strategies, and systemic lifestyle traps behind the global weight-loss craze.